Progesterone and vitamin D: Improvement after traumatic brain injury in middle-aged rats

Hormones and Behavior

Volumn 64, Issue 3, 2013, Pages 527-538

  Tang, Huiling ^a   Hua, Fang ^a   Wang, Jun ^a   Sayeed, Iqbal ^a   Wang, Xiaojing ^b   Chen, Zhengjia ^b   Yousuf, Seema ^a   Atif, Fahim ^a   Stein, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Aging; Combination treatments; Functional repair; Progesterone; Traumatic brain injury; Vitamin D deficiency; Vitamin D3 hormone

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; PROGESTERONE; VITAMIN D;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR CHANGE; BRAIN CONTUSION; CELL LOSS; CELL PROLIFERATION; COGNITION; CONTROLLED STUDY; DRUG EFFICACY; FRONTAL CORTEX; GRIP STRENGTH; LOCOMOTION; MALE; MIDDLE AGED; MONOTHERAPY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REFERENCE MEMORY; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY; VITAMIN D DEFICIENCY; VITAMIN D HORMONE DEFICIENCY;

AGING; COMBINATION TREATMENTS; FUNCTIONAL REPAIR; PROGESTERONE; TRAUMATIC BRAIN INJURY; VITAMIN D DEFICIENCY; VITAMIN D3 HORMONE;

AGING; ANIMALS; BRAIN INJURIES; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84884128544     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2013.06.009     Document Type: Article

References (70)

1. Annweiler C., Schott A.M., Allali G., Bridenbaugh S.A., Kressig R.W., Allain P., Herrmann F.R., Beauchet O. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010, 74:27-32.
2. Atalay B., Caner H., Can A., Cekinmez M. Attenuation of microtubule associated protein-2 degradation after mild head injury by mexiletine and calpain-2 inhibitor. Br. J. Neurosurg. 2007, 21(3):281-287.
3. Atif F., Sayeed I., Ishrat T., Stein D.G. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol. Med. 2009, 15(9-10):328-336.
4. Atif F., Yousuf S., Sayeed I., Ishrat T., Hua F., Stein D.G. Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection. Neuropharmacology 2013, 67:78-87. (Epub ahead of print).
5. Balden R., Selvamani A., Sohrabji F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology 2012, 153(5):2420-2435. (Epub 2012 Mar 9).
6. Baldi E., Efoudebe M., Lorenzini C.A., Bucherelli C. Spatial navigation in the Morris water maze: working and long lasting reference memories. Neurosci. Lett. 2005, 378(3):176-180.
7. Becker A., Eyles D.W., McGrath J.J., Grecksch G. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav. Brain Res. 2005, 161(2):306-312.
8. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 2001, 21:98-108.
9. Briones T.L., Darwish H. Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. J. Neuroinflammation 2012, 9(1):244.
10. Buell J.S., Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D"ecline?. Mol. Aspects Med. 2010, 29(6):415-422.
11. Cai W., Zhu Y., Furuya K., Li Z., Sokabe M., Chen L. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 2008, 55:127-138.
12. Carroll J.C., Rosario E.R., Villamagna A., Pike C.J. Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology 2010, 151(6):2713-2722. (Epub 2010 Apr 21). 10.1210/en.2009-1487.
13. Cekic M., Cutler S.M., VanLandingham J.W., Stein D.G. Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol. Aging 2011, 32(5):864-874.
14. Chatterjee M. Vitamin D and genomic stability. Mutat. Res. 2001, 475:69-87.
15. Chesler E.J., Juraska J.M. Acute administration of estrogen and progesterone impairs the acquisition of the spatial Morris water maze in ovariectomized rats. Horm. Behav. 2000, 38:234-242.
16. Chisholm N.C., Juraska J.M. Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model. Brain Res. 2013, 1514C:40-49. (Epub 2013 Feb 16). 10.1016/j.brainres.2013.02.020.
17. Chisholm N.C., Packard A.R., Koss W.A., Juraska J.M. The effects of long-term treatment with estradiol and medroxyprogesterone acetate on tyrosine hydroxylase fibers and neuron number in the medial prefrontal cortex of aged female rats. Endocrinology 2012, 153(10):4874-4882.
18. Cutler S.M., Vanlandingham J.W., Stein D.G. Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp. Neurol. 2006, 200(2):378-385.
19. Cutler S.M., Cekic M., Miller D.M., Wali B., VanLandingham J.W., Stein D.G. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 2007, 24(9):1475-1486.
20. Deluca G.C., Kimball S.M., Kolasinski J., Ramagopalan S.V., Ebers G.C. The role of vitamin D in nervous system health and disease. Neuropathol. Appl. Neurobiol 2013, (Epub ahead of print). 10.1111/nan.12020.
21. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cellbased ALS model. Nat. Neurosci. 2007, 10(5):608-614.
22. Diamond T.H., Ho K.W., Rohl P.G., Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med. J. 2005, 183(1):10-12.
23. Drewes G., Ebneth A., Mandelkow E.M. MAPs, MARKs and microtubule dynamics. Trends Biochem. Sci. 1998, 23(8):307-311.
24. Ehara A., Ueda S. Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences. Acta Histochem. Cytochem. 2009, 42(6):171-179.
25. Ercan M., Inci S., Kilinc K., Palaoglu S., Aypar U. Nimodipine attenuates lipid peroxidation during the acute phase of head trauma in rats. Neurosurg. Rev. 2001, 24:127-130.
26. Evatt M.L., Delong M.R., Khazai N., Rosen A., Triche S., Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch. Neurol. 2008, 65(10):1348-1352.
27. Evatt M.L., DeLong M.R., Kumari M., Auinger P., McDermott M.P., Tangpricha V., Parkinson Study Group DATATOP Investigators High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch. Neurol. 2011, 68(3):314-319.
28. Eyles D.W., Burne T.H., McGrath J.J. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front. Neuroendocrinol. 2013, 34(1):47-64. 10.1016/j.yfrne.2012.07.001.
29. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28(3):138-145.
30. Felmingham K.L., Fong W.C., Bryant R.A. The impact of progesterone on memory consolidation of threatening images in women. Psychoneuroendocrinology 2012, 37(11):1896-1900. 10.1016/j.psyneuen.2012.03.026.
31. Fernandes de Abreu D.A., Nivet E., Baril N., Khrestchatisky M., Roman F., Féron F. Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav. Brain Res. 2010, 208(2):603-608.
32. Frick K.M., Baxter M.G., Markowska A.L., Olton D.S., Price D.L. Age-related spatial reference and working memory deficits assessed in the water maze. Neurobiol. Aging 1995, 16(2):149-160.
33. Frick K.M., Burlingame L.A., Arters J.A., Berger-Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience 2000, 95(1):293-307.
34. Gage F.H., Dunnett S.B., Bjorklund A. Age-related impairments in spatial memory are independent of those in sensorimotor skills. Neurobiol. Aging 1989, 10(4):347-352.
35. Galea L.A., Ormerod B.K., Sampath S., Kostaras X., Wilkie D.M., Phelps M.T. Spatial working memory and hippocampal size across pregnancy in rats. Horm. Behav. 2000, 37(1):86-95.
36. Gallagher M., Rapp P.R. The use of animal models to study the effects of aging on cognition. Annu. Rev. Psychol. 1997, 48:339-370.
37. Goss C.W., Hoffman S.W., Stein D.G. Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol. Biochem. Behav. 2003, 76(2):231-242.
38. Heaney R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr. 2004, 80(6 Suppl.):1706S-1709S.
39. Hedden T., Gabrieli J.D. Insights into the ageing mind: a view from cognitive neuroscience. Nat. Rev. Neurosci. 2004, 5:87-96.
40. Holick M.F. Vitamin D deficiency in CKD: why should we care?. Am. J. Kidney Dis. 2005, 45(6):1119-1121.
41. Hu Z., Li Y., Fang M., Wai M.S., Yew D.T. Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegeneration. Curr. Med. Chem. 2009, 16:1418-1425.
42. Hua F., Wang J., Ishrat T., Wei W., Atif F., Sayeed I., Stein D.G. Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J. Neuroinflammation 2011, 8:42.
43. Hua F., Reiss J.I., Tang H., Wang J., Fowler X., Sayeed I., Stein D.G. Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury. Horm. Behav. 2012, 61(4):642-651.
44. John G.R., Lee S.C., Brosnan C.F. Cytokines: powerful regulators of glial cell activation. Neuroscientist 2003, 9(1):10-22.
45. Kojima G., Bell C., Abbott R.D., Launer L., Chen R., Motonaga H., Ross G.W., Curb J.D., Masaki K. Low dietary vitamin D predicts 34-year incident stroke: the Honolulu Heart Program. Stroke 2012, 43(8):2163-2167.
46. Kuningas M., Mooijaart S.P., Jolles J., Slagboom P.E., Westendorp R.G., van Heemst D. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol. Aging 2009, 30(3):466-473.
47. Lin A.M., Chen K.B., Chao P.L. Antioxidative effect of vitamin D3 on zincinduced oxidative stress in CNS. Ann. N. Y. Acad. Sci. 2005, 1053:319-329.
48. Liu A., Margaill I., Zhang S., Labombarda F., Coqueran B., Delespierre B., Liere P., Marchand-Leroux C., O'Malley B.W., Lydon J.P., De Nicola A.F., Sitruk-Ware R., Mattern C., Plotkine M., Schumacher M., Guennoun R. Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology 2012, 153(8):3747-3757. (Epub 2012 May 25). 10.1210/en.2012-1138.
49. Luckhaus C., Mahabadi B., Grass-Kapanke B., Jänner M., Willenberg H., Jäger M., Supprian T., Fehsel K. Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J. Neural Transm. 2009, 116(7):905-911.
50. Maas A.I., Marmarou A., Murray G.D., Teasdale S.G., Steyerberg E.W. Prognosis and clinical trial design in traumatic brain injury: the Impact study. J. Neurotrauma 2007, 24(2):232-238.
51. Margulies S., Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J. Neurotrauma 2009, 26(6):925-939.
52. Markham J.A., Juraska J.M. Aging and sex influence the anatomy of the rat anterior cingulate cortex. Neurobiol. Aging 2002, 23:579-588.
53. Markowska A.L., Stone W.S., Ingram D.K., Reynolds J., Gold P.E., Conti L.H., Pontecorvo M.J., Wenk G.L., Olton D.S. Individual differences in aging: behavioral and neurobiological correlates. Neurobiol. Aging 1989, 10(1):31-43.
54. McCann J.C., Ames B.N. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J. 2008, 22(4):982-1001.
55. Minasyan A., Keisala T., Lou Y.R., Kalueff A.V., Tuohimaa P. Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol. 2007, 104(3-5):274-280.
56. Narayanan R., Allen M.R., Gaddy D., Bloomfield S.A., Smith C.L., Weigel N.L. Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089). Bone 2004, 35(1):134-143.
57. Newmark H.L., Newmark J. Vitamin D and Parkinson's disease-a hypothesis. Mov. Disord. 2007, 22(4):461-468.
58. Paris J.J., Walf A.A., Frye C.A. Cognitive performance of middle-aged female rats is influenced by capacity to metabolize progesterone in the prefrontal cortex and hippocampus. Brain Res. 2011, 1379:149-163.
59. Paulson P.E., Robinson T.E. Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav. Neurosci. 1994, 108:624-635.
60. Pettus E.H., Wright D.W., Stein D.G., Hoffman S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 2005, 1049(1):112-119.
61. Sarkaki A.R., Khaksari H.M., Soltani Z., Shahrokhi N., Mahmoodi M. Time- and dose-dependent neuroprotective effects of sex steroid hormones on inflammatory cytokines after a traumatic brain injury. J. Neurotrauma 2013, 30(1):47-54. (Epub 2012 Nov 16). 10.1089/neu.2010.1686.
62. Sharma N., Kress Y., Shafit-Zagardo B. Antisense MAP-2 oligonucleotides induce changes in microtubule assembly and neuritic elongation in pre-existing neurites of rat cortical neurons. Cell Motil. Cytoskeleton 1994, 27:234-247.
63. Solomon J.A., Gianforcaro A., Hamadeh M.J. Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis. PLoS One 2011, 6(12):e29354. (Epub 2011 Dec 27).
64. Staffa K., Ondruschka B., Franke H., Dreßler J. Cerebellar gene expression following human traumatic brain injury. J. Neurotrauma 2012, 29(17):2716-2721. (Epub 2012 Nov 20). 10.1089/neu.2011.2246.
65. Stein D.G., Cekic M.M. Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged. PM R 2011, 3(6 Suppl. 1):S100-S110.
66. Sun Q., Pan A., Hu F.B., Manson J.E., Rexrode K.M. 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 2012, 43(6):1470-1477.
67. Vallée M., Mayo W., Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res. Brain Res. Rev. 2001, 37(1-3):301-312.
68. Valtueña J., Gracia-Marco L., Huybrechts I., Breidenassel C., Ferrari M., Gottrand F., Dallongeville J., Sioen I., Gutierrez A., Kersting M., Kafatos A., Manios Y., Widhalm K., Moreno L.A., González-Gross M. Cardiorespiratory fitness in males, and upper limbs muscular strength in females, are positively related with 25-hydroxyvitamin D plasma concentrations in European adolescents: the HELENA study. QJM 2013, On Behalf Of The Helena Study Group, http://dx.doi.org/10.1093/qjmed/hct089 (Epub 2013 May 8).
69. Velíšková J., Desantis K.A. Sex and hormonal influences on seizures and epilepsy. Horm. Behav. 2013, 63(2):267-277. (Epub 2012 Apr 4). 10.1016/j.yhbeh.2012.03.018.
70. Wali B., Sayeed I., Stein D.G. Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor. Neurol. Neurosci. 2011, 29(1):61-71.